Incretin-based medications for obesity, and an uncertainty that tracks income
The Lancet Primary Care · 2026-11 · 100228
DOI: 10.1016/j.lanprc.2026.100228 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Lancet Primary Care, 2026-11. Verfasst von Romain Lutaud und 6 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lutaud, R., Czernichow, S., Gentile, G., Dutour, A., Levy, L., Coz, P. L., & Darmon, P. (2026). Incretin-based medications for obesity, and an uncertainty that tracks income. The Lancet Primary Care, 100228. https://doi.org/10.1016/j.lanprc.2026.100228
Vancouver
Lutaud R, Czernichow S, Gentile G, Dutour A, Levy L, Coz PL, et al. Incretin-based medications for obesity, and an uncertainty that tracks income. The Lancet Primary Care. 2026:100228. doi:10.1016/j.lanprc.2026.100228
BibTeX
@article{Lutaud2026,
author = {Lutaud, Romain and Czernichow, Sébastien and Gentile, Gaétan and Dutour, Anne and Levy, Laetitia and Coz, Pierre Le and Darmon, Patrice},
title = {Incretin-based medications for obesity, and an uncertainty that tracks income},
journal = {The Lancet Primary Care},
year = {2026},
pages = {100228},
doi = {10.1016/j.lanprc.2026.100228}
}
EUVIMED